{
    "medicine_id": "a4c43f87178f0c70d1afe3dc3f2ed006787c056e",
    "platform_id": "DB13209",
    "metadata": {
        "name": "Hemorro dol Sup Suppository",
        "composition": "Bismuth subnitrate",
        "clinical_particulars": {
            "therapeutic_indications": "Indicated for over the counter use as an antacid",
            "contraindications": {
                "disease": "Reported oral dose range for moderate toxicity or possibly lethal toxicity in humans is 0 5 5 g kg L2733 Nephropathy encephalopathy osteoarthropathy gingivitis stomatitis and colitis have been attributed to bismuth toxicity in humans A33021",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Bismuth subnitrate acts as an antacid that exert protective effects on the gastric mucosa A33012 In a double blind endoscopically controlled study bismuth substrate was demonstrated to be effective for symptomatic relief in duodenal ulcers A33013 In the alcohol model of mucosal injury in the rat bismuth substrate was shown to be cytoprotective A33013 In a randomized clinical study consisting of patients with _H pylori_ associated duodenal ulcer adjunctive use of colloidal bismuth subnitrate in a short treatment regimen with omeprazole and clarithromycin resulted in improved eradication rate of _H pylori_ A33014",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB01072",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "The serum concentration of Cefditoren can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Delavirdine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Erlotinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "Bismuth subnitrate can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01344",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09020",
                        "description": "The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "The serum concentration of Cefpodoxime can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "The serum concentration of Cefuroxime can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09101",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Elvitegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Rifampicin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Bismuth subnitrate may decrease the excretion rate of Mecamylamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Bismuth subnitrate may decrease the excretion rate of Memantine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Bismuth subnitrate may decrease the excretion rate of Quinidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The therapeutic efficacy of Sulpiride can be increased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "The therapeutic efficacy of Allopurinol can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB06817",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Mycophenolate mofetil resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Mycophenolic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00847",
                        "description": "The bioavailability of Cysteamine can be decreased when combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01294",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09275",
                        "description": "Bismuth subcitrate potassium may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13909",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Bismuth subgallate"
                    },
                    {
                        "drugbank-id": "DB13910",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Valproate bismuth"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Thiethylperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Promazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Prochlorperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Chlorpromazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Triflupromazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Thioridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Moricizine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Perphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Acetophenazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Promethazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Alimemazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Methotrimeprazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Periciazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Acepromazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Aceprometazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Pipotiazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Thioproperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of BL 1020 resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Cyamemazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Methylene blue resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Propiopromazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Perazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Butaperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Chlorproethazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Thiazinam resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Dixyrazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Perphenazine enanthate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06799",
                        "description": "The therapeutic efficacy of Methenamine can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Doxycycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00256",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00453",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00595",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00618",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00931",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Sarecycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13264",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Penimepicycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06824",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "The serum concentration of Pamidronic acid can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00399",
                        "description": "The serum concentration of Zoledronic acid can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00630",
                        "description": "The serum concentration of Alendronic acid can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The serum concentration of Ibandronate can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00720",
                        "description": "The serum concentration of Clodronic acid can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00884",
                        "description": "The serum concentration of Risedronic acid can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01077",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "The serum concentration of Tiludronic acid can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB06255",
                        "description": "The serum concentration of Incadronic acid can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The serum concentration of Amphetamine can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The serum concentration of Phentermine can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The serum concentration of Pseudoephedrine can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The serum concentration of Benzphetamine can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The serum concentration of Diethylpropion can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The serum concentration of Lisdexamfetamine can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The serum concentration of Mephentermine can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The serum concentration of MMDA can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The serum concentration of Midomafetamine can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The serum concentration of 2 5 Dimethoxy 4 ethylamphetamine can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The serum concentration of 4 Bromo 2 5 dimethoxyamphetamine can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The serum concentration of Tenamfetamine can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The serum concentration of Chlorphentermine can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "The serum concentration of Methylenedioxyethamphetamine can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The serum concentration of Dextroamphetamine can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The serum concentration of Metamfetamine can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The serum concentration of Iofetamine I 123 can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The serum concentration of Ritobegron can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The serum concentration of Mephedrone can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The serum concentration of Methoxyphenamine can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The serum concentration of Gepefrine can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The serum concentration of 2 5 Dimethoxy 4 ethylthioamphetamine can be increased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Acetaminophen resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Propacetamol resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01377",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01378",
                        "description": "The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "The therapeutic efficacy of Sorbitol can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "The therapeutic efficacy of Magnesium hydroxide can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "The therapeutic efficacy of Magnesium trisilicate can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09287",
                        "description": "The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09413",
                        "description": "The therapeutic efficacy of Monopotassium phosphate can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09414",
                        "description": "The therapeutic efficacy of Dipotassium phosphate can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09449",
                        "description": "The therapeutic efficacy of Sodium phosphate monobasic can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09462",
                        "description": "The therapeutic efficacy of Glycerin can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "The therapeutic efficacy of Magnesium carbonate can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09484",
                        "description": "The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB11110",
                        "description": "The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB11189",
                        "description": "The therapeutic efficacy of Magnesium glycinate can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB12942",
                        "description": "The therapeutic efficacy of Lactitol can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13526",
                        "description": "The therapeutic efficacy of Pentaerithrityl can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13707",
                        "description": "The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB14482",
                        "description": "The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "The therapeutic efficacy of Potassium sulfate can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB14502",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB14503",
                        "description": "The therapeutic efficacy of Sodium phosphate monobasic unspecified form can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB14504",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic unspecified form can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB14516",
                        "description": "The therapeutic efficacy of Sodium cation can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB14546",
                        "description": "The therapeutic efficacy of Sulfate ion can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "Cyclosporine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "Succinylcholine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "Reserpine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "Ziprasidone may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00260",
                        "description": "Cycloserine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "Amitriptyline may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "Protriptyline may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "Vinorelbine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "Clozapine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "Loxapine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "Remoxipride may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "Teniposide may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "Droperidol may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "Imipramine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "Haloperidol may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "Cyclophosphamide may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "Nortriptyline may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "Vincristine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "Amoxapine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00649",
                        "description": "Stavudine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "Trimipramine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "Risperidone may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "Flupentixol may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Ethanol may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "Didanosine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "Cyclobenzaprine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "Pimozide may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "Doxepin may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "Desipramine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01190",
                        "description": "Clindamycin may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "Tubocurarine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "Paclitaxel may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "Aripiprazole may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "Chlorprothixene may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "Clomipramine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "Decamethonium may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "Paliperidone may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "Lithium cation may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01598",
                        "description": "Imipenem may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "Molindone may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "Thiothixene may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "Zuclopenthixol may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB01627",
                        "description": "Lincomycin may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "Amineptine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "Fluspirilene may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "Osanetant may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "Bifeprunox may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "Iloperidone may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "Pimavanserin may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "Cariprazine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "Sertindole may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "Asenapine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "Amisulpride may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "Lurasidone may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "Perospirone may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "Amperozide may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "Dimetacrine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "Butriptyline may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "Brexpiprazole may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "Sodium citrate may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "Dosulepin may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "Blonanserin may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "Melperone may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "Zotepine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "Brilaroxazine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "Pipamperone may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "Tianeptine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "Oxaprotiline may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "Azaperone may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB11537",
                        "description": "Pirlimycin may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "Tetrahydropalmatine may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "Ecopipam may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "Bromperidol may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "Raclopride may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "Ritanserin may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "Benperidol may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "Opipramol may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "Prothipendyl may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "Tiapride may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "Amitriptylinoxide may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Dibenzepin"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Quinupramine"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Clothiapine"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Sultopride"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Melitracen"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Oxypertine"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Lofepramine"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Iprindole"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Veralipride"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Trifluperidol"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Moperone"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Thiopropazate"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Gallamine"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Fluanisone"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Mosapramine"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Imipramine oxide"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Penfluridol"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Clopenthixol"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB00781",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Polymyxin B"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "Neomycin may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB06827",
                        "description": "Viomycin may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB15965",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Nelfinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Ritonavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Amprenavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Tipranavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01264",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01319",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Fosamprenavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Asunaprevir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB15623",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of TMC 310911 resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The therapeutic efficacy of Lactulose can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The absorption of Palbociclib can be decreased when combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Dexmethylphenidate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The risk or severity of adverse effects can be increased when Bismuth subnitrate is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The serum concentration of Digoxin can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "The serum concentration of Metildigoxin can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The serum concentration of Acetyldigoxin can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "Naproxen can cause a decrease in the absorption of Bismuth subnitrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Hydroxychloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The serum concentration of Selpercatinib can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}